Head and Neck Radiology: Page 34

Reirradiation of brain metastases offers limited help
By AuntMinnie.com staff writers
Cancer patients with brain metastases that recur after initial radiotherapy don't have long to live. Is reirradiation worthwhile? A study published online February 9 in the Japanese Journal of Clinical Oncology determined that this treatment extended life only by several months and caused a high level of lethargy.
March 2, 2012
DOPA-PET/CT changes brain tumor treatment
By AuntMinnie.com staff writers
Imaging with PET/CT and the radiopharmaceutical fluorine-18 dihydroxyphenylalanine (F-18 DOPA) can significantly alter treatment management plans for patients with brain tumors, according to a study in the March issue of the Journal of Nuclear Medicine.
March 1, 2012
NinePoint starts clinical trial, names VP
By AuntMinnie.com staff writers
Optical coherence tomography developer NinePoint Medical has begun a clinical trial to evaluate high-resolution optical imaging of Barrett's esophagus using the company's Nvision VLE imaging system.
February 23, 2012
Elekta gets FDA OK for Fraxion head frame
By AuntMinnie.com staff writers
Oncology firm Elekta has received clearance from the U.S. Food and Drug Administration for its Fraxion head frame.
February 16, 2012
Low reader confidence in CAD hinders results in MRA screening
By Erik L. Ridley
Computer-aided detection (CAD) technology can be a valuable tool for improving the detection of cerebral aneurysms, but researchers from the University of Tokyo found that a lack of reader confidence in CAD findings can impede its effectiveness when used for MR angiography (MRA) screening.
February 14, 2012
FDG-PET/CT helps manage retinoblastoma cancer
By Wayne Forrest
Optic nerve uptake at baseline on an FDG-PET/CT scan and response after neoadjuvant chemotherapy are strong predictors of event-free and overall survival for young children with stage III retinoblastoma, according to a study in the February issue of the Journal of Nuclear Medicine.
February 13, 2012
2012 02 14 10 23 14 446 Jnm Retinoblastoma Thumb
PET/CT detects head/neck cancer recurrences earlier
By Cynthia E. Keen
Routine use of follow-up PET/CT scans can detect local cancer recurrences before they become clinically apparent, and may improve outcomes of subsequent salvage therapy, according to a study presented on Friday at the Multidisciplinary Head and Neck Cancer Symposium in Phoenix.
January 27, 2012
IMRT offers better outcome for head/neck cancer patients
By Cynthia E. Keen
Patients treated with intensity-modulated radiation therapy (IMRT) for head and neck cancer reported increasingly better quality of life after treatment than patients receiving other forms of radiotherapy, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium in Phoenix.
January 26, 2012
CT not cost-effective to investigate dizziness
By AuntMinnie.com staff writers
Performing head CT scans in the emergency room isn't cost-effective for patients complaining of dizziness, according to a study presented on January 26 at the Triological Society's Combined Sections Meeting in Miami Beach, FL.
January 25, 2012
HIV lowers RT response in head/neck cancer
By AuntMinnie.com staff writers
Radiation therapy with or without chemotherapy is less effective for HIV-positive than HIV-negative head and neck cancer patients in terms of recurrence and overall survival rates, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, which starts today in Phoenix.
January 25, 2012
Oral HPV infection increasing in young men
By AuntMinnie.com staff writers
The incidence of oral human papillomavirus (HPV) infection, the principal cause of a form of oropharyngeal squamous cell carcinoma, is increasing in young men in the U.S., according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, which begins today in Phoenix.
January 25, 2012
Chromosomal abnormality guides rad therapy
By AuntMinnie.com staff writers
The Radiation Therapy Oncology Group (RTOG) has released clinical trial results indicating that a chromosomal abnormality -- specifically, the absence of chromosomes 1p and 19q -- has prognostic and predictive value for managing the treatment of adult patients with rare brain tumors.
January 19, 2012
Previous Page
Page 34 of 78
Next Page